Heritage Distilling (NASDAQ:IPST – Get Free Report) and Coeptis Therapeutics (NASDAQ:ZSQR – Get Free Report) are both small-cap technology companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, dividends, analyst recommendations, risk, profitability and institutional ownership.
Profitability
This table compares Heritage Distilling and Coeptis Therapeutics’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Heritage Distilling | -1,875.66% | -242.58% | -201.22% |
| Coeptis Therapeutics | -773.72% | -49.45% | -46.88% |
Analyst Recommendations
This is a breakdown of current ratings and target prices for Heritage Distilling and Coeptis Therapeutics, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Heritage Distilling | 1 | 1 | 1 | 0 | 2.00 |
| Coeptis Therapeutics | 1 | 0 | 0 | 0 | 1.00 |
Insider & Institutional Ownership
13.9% of Coeptis Therapeutics shares are owned by institutional investors. 3.7% of Heritage Distilling shares are owned by company insiders. Comparatively, 24.2% of Coeptis Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Earnings and Valuation
This table compares Heritage Distilling and Coeptis Therapeutics”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Heritage Distilling | $10.12 million | 0.20 | -$137.71 million | ($311.78) | -0.01 |
| Coeptis Therapeutics | $1.36 million | 114.96 | -$11.92 million | ($1.63) | -1.81 |
Coeptis Therapeutics has lower revenue, but higher earnings than Heritage Distilling. Coeptis Therapeutics is trading at a lower price-to-earnings ratio than Heritage Distilling, indicating that it is currently the more affordable of the two stocks.
Volatility & Risk
Heritage Distilling has a beta of 5.41, indicating that its share price is 441% more volatile than the S&P 500. Comparatively, Coeptis Therapeutics has a beta of -0.25, indicating that its share price is 125% less volatile than the S&P 500.
Summary
Coeptis Therapeutics beats Heritage Distilling on 8 of the 14 factors compared between the two stocks.
About Heritage Distilling
Heritage Distilling Holding Company Inc. is a craft distiller of premium brands, including whiskeys, vodkas, gins, rums and ready-to-drink canned cocktails. Heritage Distilling Holding Company Inc. is based in GIG HARBOR, Wash.
About Coeptis Therapeutics
Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological malignancies and solid tumors; and CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy. The company also offers its drugs for acute myeloid leukemia and acute respiratory diseases. Coeptis Therapeutics Holdings, Inc. has co-development agreement Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. The company was founded in 2017 and is headquartered in Wexford, Pennsylvania.
Receive News & Ratings for Heritage Distilling Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heritage Distilling and related companies with MarketBeat.com's FREE daily email newsletter.
